US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ARDX

Ardelyx (ARDX)

Ardelyx Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/08/02	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARDX	Ardelyx Inc
2024/08/02	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
2024/08/02	05 : 01	GlobeNewswire Inc.	Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARDX	Ardelyx Inc
2024/07/31	21 : 02	GlobeNewswire Inc.	Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion	NASDAQ:ARDX	Ardelyx Inc
2024/07/18	21 : 00	GlobeNewswire Inc.	Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024	NASDAQ:ARDX	Ardelyx Inc
2024/07/18	06 : 10	GlobeNewswire Inc.	Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines	NASDAQ:ARDX	Ardelyx Inc
2024/07/02	20 : 00	GlobeNewswire Inc.	To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA	NASDAQ:ARDX	Ardelyx Inc
2024/06/28	21 : 17	GlobeNewswire Inc.	Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines	NASDAQ:ARDX	Ardelyx Inc
2024/06/18	07 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/18	07 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/18	07 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/17	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
2024/06/14	05 : 12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/08	07 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/06	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/06	07 : 09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ARDX	Ardelyx Inc
2024/06/04	21 : 57	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARDX	Ardelyx Inc
2024/05/31	05 : 02	GlobeNewswire Inc.	Ardelyx, Inc. Reports Employment Inducement Grants	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05 : 58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/24	05 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/05/22	21 : 02	GlobeNewswire Inc.	Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
2024/05/21	21 : 02	GlobeNewswire Inc.	Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults	NASDAQ:ARDX	Ardelyx Inc
2024/05/16	21 : 01	GlobeNewswire Inc.	Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)	NASDAQ:ARDX	Ardelyx Inc
2024/05/15	05 : 02	GlobeNewswire Inc.	Ardelyx, Inc. Reports Employment Inducement Grants	NASDAQ:ARDX	Ardelyx Inc
2024/05/10	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc

Showing the most relevant articles for your search:NASDAQ:ARDX

1 2 3 4 5 6 7 8 9 10 次へ >>

American Express

Energy Select Sector SPDR

BNP Paribas (QX)

Deutsche Telekom (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約